The first interactive session for Mr. Jonathan Heimer, Honorary National Executive Board Member, AMCHAM and Minister Counselor for Commercial Affairs, U.S. Embassy with AMCHAM’s Pharmaceutical Committee was organized under the chairmanship of Mr. Umang Chaturvedi, Chairman – Pharmaceutical Committee, AMCHAM and Head of Policy & International Affairs, Mylan and Ms. Jyotsna Ghosal, Co-Chairperson – Pharmaceutical Committee, AMCHAM and Executive Director – Corp Communications, Johnson and Johnson on November 7th at the Boston Scientific office in Gurugram in a hybrid fashion.

Approximately 20 members participated in the session. Some of the priority issues highlighted included the issues and challenges pertaining to market access barriers, PPO, NLEM and TMR, pricing, regulatory barriers, IP barriers, state engagements etc. It was suggested to share top priority issues and challenges with recommendations to the Embassy in order to seek support for policy intervention. It was also suggested to sessions on partnering with the government, awareness level sessions on NCD, life-course immunization and prevention, etc. Strong engagements with policy makers and USG officials were also highlighted as key initiatives for the year. The committee decided to organize a MedTech and pharma flagship event in 2023.